The Latest SPAC News and Rumors: September 15, 2021
by Marlena Haddad on 2021-09-15 at 11:51am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Carousell becomes Singapore’s newest unicorn, Acorns names former Amazon executive as president, and Anghami partners with Amazon Prime


Online Marketplace Carousell Is Singapore’s Newest Unicorn

Online classifieds marketplace Carousell Pte became Singapore’s latest tech unicorn, raising funds at a $1.1 billion valuation as Southeast Asia’s e-commerce startups benefit from the pandemic and related lockdowns, according to Bloomberg.

The company got $100 million in a round led by South Korean private equity firm STIC Investments.

Carousell has weighed a U.S. listing via a merger with a blank-check company, people with knowledge of the matter said in June.

READ

Acorns Names Amazon Alum David Hijirida as President Ahead of IPO

Acorns Grow Inc. hired former Amazon.com Inc. executive David Hijirida as its president, as the savings and investing startup prepares to go public by merging with a blank-check company.

On May 27, Acorns entered into a definitive agreement to combine with Pioneer Merger Corp. (NASDAQ:PACX).

READ

Amazon Prime and Anghami Collaborate in Saudi Arabia and United Arab Emirates with Anghami Plus

Amazon and Anghami have today announced that Amazon Prime members in Saudi Arabia and the UAE can enjoy an exclusive six-months free offer on Anghami Plus, Anghami’s premium paid tier, with their Prime membership.

Prime members in Saudi Arabia and the UAE will receive a free six-month subscription to Anghami Plus, followed by 50% off the subscription fee for the next six months.

On March 3, Anghami entered into a definitive agreement to combine with Vistas Media (NASDAQ:VMAC).

READ

SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza  

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today announced the completion of enrollment in its Phase 2a clinical trial evaluating the safety and efficacy of SAB-176 in a challenge study.

SAB-176 is a novel anti-influenza human immunotherapy designed to address the limitations of current treatments for moderate to severe seasonal influenza.

On June 22, SAB announced a planned merger with Big Cypress Acquisition Corp. (NASDAQ: BCYP).

READ

Recent Posts
by Nicholas Alan Clayton on 2025-03-13 at 8:17am

At the SPAC of Dawn Following Wednesday’s positive CPI readings, the market is set to ingest both new jobless claims and Core PPI inflation numbers at 8:30 am ET. It might take a particularly rosy result to offset the many factors of market volatility recent. One new one got added to the bingo card this...

by Nicholas Alan Clayton on 2025-03-12 at 3:48pm

One of the eternal questions surrounding SPACs has been their ability or inability to match the opportunity and the performance of the traditional IPO route, and it has become received wisdom on Wall Street that SPACs don’t match up. This is ostensibly born out in in the aggregate statistics that are frequently cited. But, downside...

by Nicholas Alan Clayton on 2025-03-12 at 8:17am

At the SPAC of Dawn Despite the specter of recession looming, many of the hot technology sectors that SPACs favored during the boom times appear to be coming back on the menu. Ares II (NYSE:AACT) is reportedly angling to lock down a deal with an autonomous trucking firm. Northern Genesis II and Reinvent Y each...

by Nicholas Alan Clayton on 2025-03-11 at 12:05pm

Cantor Equity Partners II (NASDAQ:CEPT) filed another warrantless SPAC showing that the firm will not be slowing down despite Cantor CEO Howard Lutnick moving his attentions to the administration. The new $200 million SPAC would join Cantor Equity Partners I (NASDAQ:CEPO), which became the first SPAC to IPO this year and Cantor Equity Partners (NASDAQ:CEP),...

by Nicholas Alan Clayton on 2025-03-11 at 8:19am

At the SPAC of Dawn  US market futures continue to be flash dark red after a major down day saw SPAC-favorite exchange Nasdaq lose about -4% of its value leaving it running down -9.5% on the year. The sudden downturn has been somewhat personal for the administration as Trump Media (NASDAQ:DJT) itself fell about -11.5%...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved